1 Market Overview
    1.1 Product Overview and Scope of Alzheimer's Disease Treatments
    1.2 Classification of Alzheimer's Disease Treatments by Type
        1.2.1 Overview: Global Alzheimer's Disease Treatments Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Alzheimer's Disease Treatments Revenue Market Share by Type in 2020
        1.2.3 Cholinesterase Inhibitors
        1.2.4 NMDA Antagonists
    1.3 Global Alzheimer's Disease Treatments Market by Application
        1.3.1 Overview: Global Alzheimer's Disease Treatments Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Hospitals
        1.3.3 Diagnostic Laboratories
        1.3.4 Research and Academic Laboratories
        1.3.5 Others
    1.4 Global Alzheimer's Disease Treatments Market Size & Forecast
    1.5 Global Alzheimer's Disease Treatments Market Size and Forecast by Region
        1.5.1 Global Alzheimer's Disease Treatments Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Alzheimer's Disease Treatments Market Size by Region, (2016-2021)
        1.5.3 North America Alzheimer's Disease Treatments Market Size and Prospect (2016-2026)
        1.5.4 Europe Alzheimer's Disease Treatments Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Alzheimer's Disease Treatments Market Size and Prospect (2016-2026)
        1.5.6 South America Alzheimer's Disease Treatments Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Alzheimer's Disease Treatments Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Alzheimer's Disease Treatments Market Drivers
        1.6.2 Alzheimer's Disease Treatments Market Restraints
        1.6.3 Alzheimer's Disease Treatments Trends Analysis
2 Company Profiles
    2.1 Eisai
        2.1.1 Eisai Details
        2.1.2 Eisai Major Business
        2.1.3 Eisai Alzheimer's Disease Treatments Product and Solutions
        2.1.4 Eisai Alzheimer's Disease Treatments Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 Eisai Recent Developments and Future Plans
    2.2 Forest Laboratories
        2.2.1 Forest Laboratories Details
        2.2.2 Forest Laboratories Major Business
        2.2.3 Forest Laboratories Alzheimer's Disease Treatments Product and Solutions
        2.2.4 Forest Laboratories Alzheimer's Disease Treatments Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Forest Laboratories Recent Developments and Future Plans
    2.3 H. Lundbeck
        2.3.1 H. Lundbeck Details
        2.3.2 H. Lundbeck Major Business
        2.3.3 H. Lundbeck Alzheimer's Disease Treatments Product and Solutions
        2.3.4 H. Lundbeck Alzheimer's Disease Treatments Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 H. Lundbeck Recent Developments and Future Plans
    2.4 Johnson and Johnson
        2.4.1 Johnson and Johnson Details
        2.4.2 Johnson and Johnson Major Business
        2.4.3 Johnson and Johnson Alzheimer's Disease Treatments Product and Solutions
        2.4.4 Johnson and Johnson Alzheimer's Disease Treatments Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 Johnson and Johnson Recent Developments and Future Plans
    2.5 Merz Pharma
        2.5.1 Merz Pharma Details
        2.5.2 Merz Pharma Major Business
        2.5.3 Merz Pharma Alzheimer's Disease Treatments Product and Solutions
        2.5.4 Merz Pharma Alzheimer's Disease Treatments Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 Merz Pharma Recent Developments and Future Plans
    2.6 Novartis
        2.6.1 Novartis Details
        2.6.2 Novartis Major Business
        2.6.3 Novartis Alzheimer's Disease Treatments Product and Solutions
        2.6.4 Novartis Alzheimer's Disease Treatments Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 Novartis Recent Developments and Future Plans
    2.7 Pfizer
        2.7.1 Pfizer Details
        2.7.2 Pfizer Major Business
        2.7.3 Pfizer Alzheimer's Disease Treatments Product and Solutions
        2.7.4 Pfizer Alzheimer's Disease Treatments Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 Pfizer Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Alzheimer's Disease Treatments Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Alzheimer's Disease Treatments Players Market Share
        3.2.2 Top 10 Alzheimer's Disease Treatments Players Market Share
        3.2.3 Market Competition Trend
    3.3 Alzheimer's Disease Treatments Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Alzheimer's Disease Treatments Revenue and Market Share by Type (2016-2021)
    4.2 Global Alzheimer's Disease Treatments Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
    5.1 Global Alzheimer's Disease Treatments Revenue Market Share by Application (2016-2021)
    5.2 Alzheimer's Disease Treatments Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
    6.1 North America Alzheimer's Disease Treatments Revenue by Type (2016-2026)
    6.2 North America Alzheimer's Disease Treatments Revenue by Application (2016-2026)
    6.3 North America Alzheimer's Disease Treatments Market Size by Country
        6.3.1 North America Alzheimer's Disease Treatments Revenue by Country (2016-2026)
        6.3.2 United States Alzheimer's Disease Treatments Market Size and Forecast (2016-2026)
        6.3.3 Canada Alzheimer's Disease Treatments Market Size and Forecast (2016-2026)
        6.3.4 Mexico Alzheimer's Disease Treatments Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
    7.1 Europe Alzheimer's Disease Treatments Revenue by Type (2016-2026)
    7.2 Europe Alzheimer's Disease Treatments Revenue by Application (2016-2026)
    7.3 Europe Alzheimer's Disease Treatments Market Size by Country
        7.3.1 Europe Alzheimer's Disease Treatments Revenue by Country (2016-2026)
        7.3.2 Germany Alzheimer's Disease Treatments Market Size and Forecast (2016-2026)
        7.3.3 France Alzheimer's Disease Treatments Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Alzheimer's Disease Treatments Market Size and Forecast (2016-2026)
        7.3.5 Russia Alzheimer's Disease Treatments Market Size and Forecast (2016-2026)
        7.3.6 Italy Alzheimer's Disease Treatments Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Alzheimer's Disease Treatments Revenue by Type (2016-2026)
    8.2 Asia-Pacific Alzheimer's Disease Treatments Revenue by Application (2016-2026)
    8.3 Asia-Pacific Alzheimer's Disease Treatments Market Size by Region
        8.3.1 Asia-Pacific Alzheimer's Disease Treatments Revenue by Region (2016-2026)
        8.3.2 China Alzheimer's Disease Treatments Market Size and Forecast (2016-2026)
        8.3.3 Japan Alzheimer's Disease Treatments Market Size and Forecast (2016-2026)
        8.3.4 South Korea Alzheimer's Disease Treatments Market Size and Forecast (2016-2026)
        8.3.5 India Alzheimer's Disease Treatments Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Alzheimer's Disease Treatments Market Size and Forecast (2016-2026)
        8.3.7 Australia Alzheimer's Disease Treatments Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
    9.1 South America Alzheimer's Disease Treatments Revenue by Type (2016-2026)
    9.2 South America Alzheimer's Disease Treatments Revenue by Application (2016-2026)
    9.3 South America Alzheimer's Disease Treatments Market Size by Country
        9.3.1 South America Alzheimer's Disease Treatments Revenue by Country (2016-2026)
        9.3.2 Brazil Alzheimer's Disease Treatments Market Size and Forecast (2016-2026)
        9.3.3 Argentina Alzheimer's Disease Treatments Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Alzheimer's Disease Treatments Revenue by Type (2016-2026)
    10.2 Middle East & Africa Alzheimer's Disease Treatments Revenue by Application (2016-2026)
    10.3 Middle East & Africa Alzheimer's Disease Treatments Market Size by Country
        10.3.1 Middle East & Africa Alzheimer's Disease Treatments Revenue by Country (2016-2026)
        10.3.2 Turkey Alzheimer's Disease Treatments Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Alzheimer's Disease Treatments Market Size and Forecast (2016-2026)
        10.3.4 UAE Alzheimer's Disease Treatments Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Alzheimer's Disease Treatments Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
    Table 2. Global Alzheimer's Disease Treatments Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
    Table 3. Global Market Alzheimer's Disease Treatments Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
    Table 4. Global Alzheimer's Disease Treatments Revenue (USD Million) by Region (2016-2021)
    Table 5. Global Alzheimer's Disease Treatments Revenue Market Share by Region (2021-2026)
    Table 6. Eisai Corporate Information, Head Office, and Major Competitors
    Table 7. Eisai Major Business
    Table 8. Eisai Alzheimer's Disease Treatments Product and Solutions
    Table 9. Eisai Alzheimer's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 10. Forest Laboratories Corporate Information, Head Office, and Major Competitors
    Table 11. Forest Laboratories Major Business
    Table 12. Forest Laboratories Alzheimer's Disease Treatments Product and Solutions
    Table 13. Forest Laboratories Alzheimer's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 14. H. Lundbeck Corporate Information, Head Office, and Major Competitors
    Table 15. H. Lundbeck Major Business
    Table 16. H. Lundbeck Alzheimer's Disease Treatments Product and Solutions
    Table 17. H. Lundbeck Alzheimer's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 18. Johnson and Johnson Corporate Information, Head Office, and Major Competitors
    Table 19. Johnson and Johnson Major Business
    Table 20. Johnson and Johnson Alzheimer's Disease Treatments Product and Solutions
    Table 21. Johnson and Johnson Alzheimer's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 22. Merz Pharma Corporate Information, Head Office, and Major Competitors
    Table 23. Merz Pharma Major Business
    Table 24. Merz Pharma Alzheimer's Disease Treatments Product and Solutions
    Table 25. Merz Pharma Alzheimer's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 26. Novartis Corporate Information, Head Office, and Major Competitors
    Table 27. Novartis Major Business
    Table 28. Novartis Alzheimer's Disease Treatments Product and Solutions
    Table 29. Novartis Alzheimer's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 30. Pfizer Corporate Information, Head Office, and Major Competitors
    Table 31. Pfizer Major Business
    Table 32. Pfizer Alzheimer's Disease Treatments Product and Solutions
    Table 33. Pfizer Alzheimer's Disease Treatments Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 34. Global Alzheimer's Disease Treatments Revenue (USD Million) by Players (2019-2021)
    Table 35. Global Alzheimer's Disease Treatments Revenue Share by Players (2019-2021)
    Table 36. Breakdown of Alzheimer's Disease Treatments by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 37. Alzheimer's Disease Treatments Players Head Office, Products and Services Provided
    Table 38. Alzheimer's Disease Treatments Mergers & Acquisitions in the Past Five Years
    Table 39. Alzheimer's Disease Treatments New Entrants and Expansion Plans
    Table 40. Global Alzheimer's Disease Treatments Revenue (USD Million) by Type (2016-2021)
    Table 41. Global Alzheimer's Disease Treatments Revenue Share by Type (2016-2021)
    Table 42. Global Alzheimer's Disease Treatments Revenue Forecast by Type (2021-2026)
    Table 43. Global Alzheimer's Disease Treatments Revenue by Application (2016-2021)
    Table 44. Global Alzheimer's Disease Treatments Revenue Forecast by Application (2021-2026)
    Table 45. North America Alzheimer's Disease Treatments Revenue by Type (2016-2021) & (USD Million)
    Table 46. North America Alzheimer's Disease Treatments Revenue by Type (2021-2026) & (USD Million)
    Table 47. North America Alzheimer's Disease Treatments Revenue by Application (2016-2021) & (USD Million)
    Table 48. North America Alzheimer's Disease Treatments Revenue by Application (2021-2026) & (USD Million)
    Table 49. North America Alzheimer's Disease Treatments Revenue by Country (2016-2021) & (USD Million)
    Table 50. North America Alzheimer's Disease Treatments Revenue by Country (2021-2026) & (USD Million)
    Table 51. Europe Alzheimer's Disease Treatments Revenue by Type (2016-2021) & (USD Million)
    Table 52. Europe Alzheimer's Disease Treatments Revenue by Type (2021-2026) & (USD Million)
    Table 53. Europe Alzheimer's Disease Treatments Revenue by Application (2016-2021) & (USD Million)
    Table 54. Europe Alzheimer's Disease Treatments Revenue by Application (2021-2026) & (USD Million)
    Table 55. Europe Alzheimer's Disease Treatments Revenue by Country (2016-2021) & (USD Million)
    Table 56. Europe Alzheimer's Disease Treatments Revenue by Country (2021-2026) & (USD Million)
    Table 57. Asia-Pacific Alzheimer's Disease Treatments Revenue by Type (2016-2021) & (USD Million)
    Table 58. Asia-Pacific Alzheimer's Disease Treatments Revenue by Type (2021-2026) & (USD Million)
    Table 59. Asia-Pacific Alzheimer's Disease Treatments Revenue by Application (2016-2021) & (USD Million)
    Table 60. Asia-Pacific Alzheimer's Disease Treatments Revenue by Application (2021-2026) & (USD Million)
    Table 61. Asia-Pacific Alzheimer's Disease Treatments Revenue by Region (2016-2021) & (USD Million)
    Table 62. Asia-Pacific Alzheimer's Disease Treatments Revenue by Region (2021-2026) & (USD Million)
    Table 63. South America Alzheimer's Disease Treatments Revenue by Type (2016-2021) & (USD Million)
    Table 64. South America Alzheimer's Disease Treatments Revenue by Type (2021-2026) & (USD Million)
    Table 65. South America Alzheimer's Disease Treatments Revenue by Application (2016-2021) & (USD Million)
    Table 66. South America Alzheimer's Disease Treatments Revenue by Application (2021-2026) & (USD Million)
    Table 67. South America Alzheimer's Disease Treatments Revenue by Country (2016-2021) & (USD Million)
    Table 68. South America Alzheimer's Disease Treatments Revenue by Country (2021-2026) & (USD Million)
    Table 69. Middle East & Africa Alzheimer's Disease Treatments Revenue by Type (2016-2021) & (USD Million)
    Table 70. Middle East & Africa Alzheimer's Disease Treatments Revenue by Type (2021-2026) & (USD Million)
    Table 71. Middle East & Africa Alzheimer's Disease Treatments Revenue by Application (2016-2021) & (USD Million)
    Table 72. Middle East & Africa Alzheimer's Disease Treatments Revenue by Application (2021-2026) & (USD Million)
    Table 73. Middle East & Africa Alzheimer's Disease Treatments Revenue by Country (2016-2021) & (USD Million)
    Table 74. Middle East & Africa Alzheimer's Disease Treatments Revenue by Country (2021-2026) & (USD Million)
List of Figures
    Figure 1. Alzheimer's Disease Treatments Picture
    Figure 2. Global Alzheimer's Disease Treatments Revenue Market Share by Type in 2020
    Figure 3. Cholinesterase Inhibitors
    Figure 4. NMDA Antagonists
    Figure 5. Alzheimer's Disease Treatments Revenue Market Share by Application in 2020
    Figure 6. Hospitals Picture
    Figure 7. Diagnostic Laboratories Picture
    Figure 8. Research and Academic Laboratories Picture
    Figure 9. Others Picture
    Figure 10. Global Alzheimer's Disease Treatments Revenue, (USD Million): 2020 VS 2021 VS 2026
    Figure 11. Global Alzheimer's Disease Treatments Revenue and Forecast (2016-2026) & (USD Million)
    Figure 12. Global Alzheimer's Disease Treatments Revenue Market Share by Region (2016-2026)
    Figure 13. Global Alzheimer's Disease Treatments Revenue Market Share by Region in 2020
    Figure 14. North America Alzheimer's Disease Treatments Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 15. Europe Alzheimer's Disease Treatments Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 16. Asia-Pacific Alzheimer's Disease Treatments Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 17. South America Alzheimer's Disease Treatments Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 18. Middle East and Africa Alzheimer's Disease Treatments Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 19. Alzheimer's Disease Treatments Market Drivers
    Figure 20. Alzheimer's Disease Treatments Market Restraints
    Figure 21. Alzheimer's Disease Treatments Market Trends
    Figure 22. Eisai Recent Developments and Future Plans
    Figure 23. Forest Laboratories Recent Developments and Future Plans
    Figure 24. H. Lundbeck Recent Developments and Future Plans
    Figure 25. Johnson and Johnson Recent Developments and Future Plans
    Figure 26. Merz Pharma Recent Developments and Future Plans
    Figure 27. Novartis Recent Developments and Future Plans
    Figure 28. Pfizer Recent Developments and Future Plans
    Figure 29. Global Alzheimer's Disease Treatments Revenue Share by Players in 2020
    Figure 30. Alzheimer's Disease Treatments Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    Figure 31. Global Top 3 Players Alzheimer's Disease Treatments Revenue Market Share in 2020
    Figure 32. Global Top 10 Players Alzheimer's Disease Treatments Revenue Market Share in 2020
    Figure 33. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
    Figure 34. Global Alzheimer's Disease Treatments Revenue Share by Type in 2020
    Figure 35. Global Alzheimer's Disease Treatments Market Share Forecast by Type (2021-2026)
    Figure 36. Global Alzheimer's Disease Treatments Revenue Share by Application in 2020
    Figure 37. Global Alzheimer's Disease Treatments Market Share Forecast by Application (2021-2026)
    Figure 38. North America Alzheimer's Disease Treatments Sales Market Share by Type (2016-2026)
    Figure 39. North America Alzheimer's Disease Treatments Sales Market Share by Application (2016-2026)
    Figure 40. North America Alzheimer's Disease Treatments Revenue Market Share by Country (2016-2026)
    Figure 41. United States Alzheimer's Disease Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 42. Canada Alzheimer's Disease Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 43. Mexico Alzheimer's Disease Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 44. Europe Alzheimer's Disease Treatments Sales Market Share by Type (2016-2026)
    Figure 45. Europe Alzheimer's Disease Treatments Sales Market Share by Application (2016-2026)
    Figure 46. Europe Alzheimer's Disease Treatments Revenue Market Share by Country (2016-2026)
    Figure 47. Germany Alzheimer's Disease Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 48. France Alzheimer's Disease Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 49. United Kingdom Alzheimer's Disease Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 50. Russia Alzheimer's Disease Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 51. Italy Alzheimer's Disease Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 52. Asia-Pacific Alzheimer's Disease Treatments Sales Market Share by Type (2016-2026)
    Figure 53. Asia-Pacific Alzheimer's Disease Treatments Sales Market Share by Application (2016-2026)
    Figure 54. Asia-Pacific Alzheimer's Disease Treatments Revenue Market Share by Region (2016-2026)
    Figure 55. China Alzheimer's Disease Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 56. Japan Alzheimer's Disease Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 57. South Korea Alzheimer's Disease Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 58. India Alzheimer's Disease Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 59. Southeast Asia Alzheimer's Disease Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 60. Australia Alzheimer's Disease Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 61. South America Alzheimer's Disease Treatments Sales Market Share by Type (2016-2026)
    Figure 62. South America Alzheimer's Disease Treatments Sales Market Share by Application (2016-2026)
    Figure 63. South America Alzheimer's Disease Treatments Revenue Market Share by Country (2016-2026)
    Figure 64. Brazil Alzheimer's Disease Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 65. Argentina Alzheimer's Disease Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 66. Middle East and Africa Alzheimer's Disease Treatments Sales Market Share by Type (2016-2026)
    Figure 67. Middle East and Africa Alzheimer's Disease Treatments Sales Market Share by Application (2016-2026)
    Figure 68. Middle East and Africa Alzheimer's Disease Treatments Revenue Market Share by Country (2016-2026)
    Figure 69. Turkey Alzheimer's Disease Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 70. Saudi Arabia Alzheimer's Disease Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 71. UAE Alzheimer's Disease Treatments Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 72. Methodology
    Figure 73. Research Process and Data Source